-

01:47:51 PM

Latest EW Stock Market News

EW - Edwards Lifesciences Corp

07/29/21 4:15 PM

NYSE : EW

Edwards Lifesciences Reports Second Quarter Results

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended June 30, 2021.Second Quarter Highlights and 2021 OutlookSales rebounded and grew 49 percent to $1.4 billion; underlying 1 sales grew 44 percent TAVR sales exceeded

RHEA-AI

positive

07/22/21 3:15 PM

NYSE : EW

Study Data Presented at TVT on the Economics of Minimalist TAVR, PARTNER 3 Bicuspid TAVR

Edwards Lifesciences (NYSE: EW) today announced that clinical and economic results from the 3M (multidisciplinary, multimodality, but minimalist) Transcatheter Aortic Valve Replacement (TAVR) Economic Study and the PARTNER 3 Bicuspid Registry for SAPIEN

RHEA-AI

positive

07/22/21 7:05 AM

NYSE : EW

conferencesearnings

Edwards Lifesciences To Host Earnings Conference Call On July 29, 2021

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended June 30, 2021 after the market closes on Thursday, July 29, 2021, and will host a conference call at 5:00 p.m. ET that day to discuss those results.To

RHEA-AI

neutral

06/01/21 4:15 PM

NYSE : EW

Edwards Receives Clearance For Hypotension Prediction Index Software For Noninvasive Acumen IQ Cuff

Edwards Lifesciences (NYSE: EW) today announced that Acumen Hypotension Prediction Index (HPI) software with the Acumen IQ finger cuff has received U.S. Food and Drug Administration clearance. This is the first noninvasive solution that unlocks Acumen

RHEA-AI

neutral

05/18/21 4:15 PM

NYSE : EW

clinical trial

Clinical Data Updates On Edwards' Transcatheter Mitral, Tricuspid Programs Presented At EuroPCR

Edwards Lifesciences (NYSE: EW) today announced that clinical results from the company's transcatheter mitral and tricuspid programs were presented as part of the late-breaking clinical trials at EuroPCR 2021, demonstrating positive outcomes for patients

RHEA-AI

positive

05/18/21 4:15 PM

NYSE : EW

Real-World Data Confirm Excellent Results For Bicuspid Patients Treated With Edwards SAPIEN 3 TAVR

Edwards Lifesciences (NYSE: EW) today announced the results of a real-world study comparing outcomes for patients with bicuspid aortic stenosis (AS) who were treated with SAPIEN 3 and SAPIEN 3 Ultra Transcatheter Aortic Valve Replacement (TAVR) and at

RHEA-AI

very positive

05/05/21 9:15 AM

NYSE : EW

Edwards Announces Updates From Annual Meeting

Edwards Lifesciences Corporation (NYSE: EW) today announced updates from its annual meeting, in which Edwards' stockholders voted with the board's recommendations on all proxy proposals:All eight director nominees were elected as directors of the

RHEA-AI

neutral

04/21/21 3:00 PM

NYSE : EW

covid-19

Providence Partners with Edwards Lifesciences, Cities of Irvine, Santa Ana, Costa Mesa and Tustin to Open Two Free Mass COVID-19 Vaccination Clinics

Providence, a national nonprofit health system, is partnering with Edwards Lifesciences (NYSE: EW), the Orange County -based medical technology company, and the Cities of Irvine, Santa Ana, Costa Mesa and Tustin to open two mass vaccination

RHEA-AI

neutral

04/20/21 4:15 PM

NYSE : EW

Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences (NYSE: EW) today reported financial results for the quarter ended March 31, 2021.First Quarter Highlights and 2021 OutlookSales grew 8 percent to $1.2 billion; underlying 1 sales grew 5 percent TAVR sales grew 7 percent;

RHEA-AI

positive

04/13/21 7:05 AM

NYSE : EW

conferencesearnings

Edwards Lifesciences To Host Earnings Conference Call On April 20, 2021

Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2021 after the market closes on Tuesday, April 20, 2021, and will host a conference call at 5:30 p.m. ET that day to discuss those results.To

RHEA-AI

neutral